ResMed Price Prediction

ResMed -- USA Stock  

USD 98.80  0.86  0.88%

Macroaxis is not in business of monitoring ResMed headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with ResMed brand which may create opportunities for some arbitrage if properly timed. With ResMed hype-based prediction module you can estimate the value of ResMed from the prospective of ResMed response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on ResMed over a specific investment horizon. Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

ResMed After-Hype Price Density Analysis

 Next price density 
Expected price to next headline

ResMed Estimiated After-Hype Price Volatility

April 24, 2018
Current Value
After-hype Price
Target Price Odds
 Above  Below  
ResMed is not too risky asset. Analysis and calculation of next after-hype price of ResMed is based on 2 months time horizon.

ResMed Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.07% 1.25% 0.05%  0.13% 2 Events / Month3 Events / MonthIn a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

ResMed Hype Timeline

On 24 of April ResMed is traded for 98.80. This company has historical hype elasticity of 0.05 and average elasticity to hype of competition of -0.13. ResMed is estimated to increase in value after the next headline with price going to jump to 98.02. The average volatility of media hype impact on the company stock price is about 171.23%. The price escalation on the next news is estimated to be 0.08% where as daily expected return is at this time at 0.07%. The volatility of related hype on ResMed is about 67.71% with expected price after next announcement by competition of 98.67. The company reported last year revenue of 2.2 B. Total Income to common stockholders was 285.09 M with profit before taxes, overhead, and interest of 1.2 B. Considering 30-days investment horizon, the next estimated press release will be in a few days.
Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections.

ResMed Related Hype Analysis

At Risk
DexCom(0.53) 2 per month 1.14  0.30  4.70 (2.95)  10.78 
Boston Scientific Corporation(0.37) 3 per month 1.22  0.15  2.48 (2.60)  6.25 
The Cooper Companies(6.34) 2 per month 0.00  0.0076  2.99 (2.69)  7.48 
Quest Diagnostics Incorporated(0.13) 2 per month 0.00 (0.0062)  1.47 (2.48)  5.53 
DENTSPLY SIRONA 0.24 3 per month 0.00 (0.21)  1.79 (2.54)  6.72 
ResMed 0.73 2 per month 1.06  0.14  2.14 (1.67)  5.64 
Stryker Corporation(4.67) 3 per month 1.37  0.12  2.12 (2.38)  5.58 
Teleflex Incorporated(4.47) 3 per month 2.25  0.047  2.48 (2.13)  7.96 
Varian Medical Systems(3.61) 3 per month 1.14  0.14  2.50 (1.88)  6.15 
Hologic 0.69 2 per month 0.00  0.0236  1.81 (2.16)  5.08 

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.